336 related articles for article (PubMed ID: 15232154)
1. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
Tagg JR
Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
[TBL] [Abstract][Full Text] [Related]
2. The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.
Minami M; Ohmori D; Tatsuno I; Isaka M; Kawamura Y; Ohta M; Hasegawa T
FEMS Microbiol Lett; 2009 Sep; 298(1):67-73. PubMed ID: 19594623
[TBL] [Abstract][Full Text] [Related]
3. Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.
Tagg JR
Probiotics Antimicrob Proteins; 2009 Jun; 1(1):60-6. PubMed ID: 26783132
[TBL] [Abstract][Full Text] [Related]
4. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
Wescombe PA; Upton M; Dierksen KP; Ragland NL; Sivabalan S; Wirawan RE; Inglis MA; Moore CJ; Walker GV; Chilcott CN; Jenkinson HF; Tagg JR
Appl Environ Microbiol; 2006 Feb; 72(2):1459-66. PubMed ID: 16461700
[TBL] [Abstract][Full Text] [Related]
5. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.
Hyink O; Wescombe PA; Upton M; Ragland N; Burton JP; Tagg JR
Appl Environ Microbiol; 2007 Feb; 73(4):1107-13. PubMed ID: 17194838
[TBL] [Abstract][Full Text] [Related]
6. Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.
Upton M; Tagg JR; Wescombe P; Jenkinson HF
J Bacteriol; 2001 Jul; 183(13):3931-8. PubMed ID: 11395456
[TBL] [Abstract][Full Text] [Related]
7. The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue.
Dierksen KP; Moore CJ; Inglis M; Wescombe PA; Tagg JR
FEMS Microbiol Ecol; 2007 Mar; 59(3):584-91. PubMed ID: 17069620
[TBL] [Abstract][Full Text] [Related]
8. Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?
Walls T; Power D; Tagg J
J Med Microbiol; 2003 Sep; 52(Pt 9):829-833. PubMed ID: 12909662
[TBL] [Abstract][Full Text] [Related]
9. Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.
Wescombe PA; Dyet KH; Dierksen KP; Power DA; Jack RW; Burton JP; Inglis MA; Wescombe AL; Tagg JR
Int J Microbiol; 2012; 2012():738503. PubMed ID: 22567013
[TBL] [Abstract][Full Text] [Related]
10. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
Wescombe PA; Burton JP; Cadieux PA; Klesse NA; Hyink O; Heng NC; Chilcott CN; Reid G; Tagg JR
Antonie Van Leeuwenhoek; 2006 Oct; 90(3):269-80. PubMed ID: 16871420
[TBL] [Abstract][Full Text] [Related]
11. Effect of administration of Streptococcus salivarius K12 on the occurrence of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media in 3 years old children.
Di Pierro F; Colombo M; Giuliani MG; Danza ML; Basile I; Bollani T; Conti AM; Zanvit A; Rottoli AS
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4601-4606. PubMed ID: 27874935
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults.
Di Pierro F; Adami T; Rapacioli G; Giardini N; Streitberger C
Expert Opin Biol Ther; 2013 Mar; 13(3):339-43. PubMed ID: 23286823
[TBL] [Abstract][Full Text] [Related]
13. Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.
Wescombe PA; Upton M; Renault P; Wirawan RE; Power D; Burton JP; Chilcott CN; Tagg JR
Microbiology (Reading); 2011 May; 157(Pt 5):1290-1299. PubMed ID: 21310787
[TBL] [Abstract][Full Text] [Related]
14. Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.
Barbour A; Philip K
PLoS One; 2014; 9(6):e100541. PubMed ID: 24941127
[TBL] [Abstract][Full Text] [Related]
15. Positive clinical outcomes derived from using
Di Pierro F; Colombo M; Zanvit A; Rottoli AS
Drug Healthc Patient Saf; 2016; 8():77-81. PubMed ID: 27920580
[TBL] [Abstract][Full Text] [Related]
16. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media.
Di Pierro F; Donato G; Fomia F; Adami T; Careddu D; Cassandro C; Albera R
Int J Gen Med; 2012; 5():991-7. PubMed ID: 23233809
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
Bowe WP; Filip JC; DiRienzo JM; Volgina A; Margolis DJ
J Drugs Dermatol; 2006 Oct; 5(9):868-70. PubMed ID: 17039652
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Efficacy of BLIS-Producing Probiotic K12 for the Prevention of Group A Streptococcus Pharyngitis: a Short Communication.
Di Pierro F
Probiotics Antimicrob Proteins; 2019 Mar; 11(1):332-334. PubMed ID: 29464500
[TBL] [Abstract][Full Text] [Related]
19. Something Old and Something New: An Update on the Amazing Repertoire of Bacteriocins Produced by Streptococcus salivarius.
Wescombe PA; Heng NC; Burton JP; Tagg JR
Probiotics Antimicrob Proteins; 2010 Mar; 2(1):37-45. PubMed ID: 26780899
[TBL] [Abstract][Full Text] [Related]
20. The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius.
Dempster RP; Tagg JR
Arch Oral Biol; 1982; 27(2):151-7. PubMed ID: 7044350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
